Irene Tracey, PhD and director of Oxford University's Nuffield Department of Clinical Neurosciences, is known as the "Queen of Pain," according to an editorial published in the July 2 issue of The New Yorker.
A deep-learning software that can automatically calculate left ventricular ejection fraction (LVEF) with less variability than a cardiologist recently received approval from the U.S. Food and Drug Administration (FDA).
The U.K.'s public healthcare system, NHS England, has fewer doctors, nurses, hospital beds and CT and MRI scanners than 18 comparable countries, according to a June 25 article in The Guardian.
After a year of soul searching and strategic review, GE announced its move to spin off GE Healthcare into a standalone company over the next 12 to 18 months. The goal, the company said, is a leaner corporate structure with substantial reductions in debt.
Resting state fMRI implemented into a clinical picture archiving and communication system (PACS) to identify eloquent cortex in patients unable to participate in a task-based study displayed a lower failure rate than standard MRI, according to research published in PLOS One.
Radiation oncologists will head to Capitol Hill Tuesday, June 26, to urge Congress to protect policies that preserve cancer patients' access to high-quality and value-centered care, during the 15th American Society for Radiation Oncology (ASTRO) Advocacy Day.
As artificial intelligence (AI) and medical imaging continue to transform clinical practice, radiologists-in-training can no longer take a passive role in the march toward this coming change.
Although findings from the 2011 National Lung Screening Trial have prompted many U.S. health organizations to endorse the use of low-dose chest CT to screen for lung cancer, research published in the American Journal of Roentgenology revealed almost 98 percent of online patient education materials outlining the benefits and risks of lung cancer screenings do not meet national literacy recommendations.
A new study from Queen’s University Belfast researchers found the eye may be a critical indicator for Alzheimer’s disease (AD) along with a host of other neurodegenerative diseases.
